HeartSciences combines current research and understanding of heart disease along with the latest advances in wavelet signal processing and artificial Intelligence to develop breakthrough technology for the early detection of heart disease.
Formed in 2008, HeartSciences (formerly known as Heart Test Laboratories) is a privately held medical technology company located in the Dallas-Fort Worth metroplex, the largest economic area in the Southern United States. For a decade, HeartSciences has been dedicated to the development of accurate, affordable cardiac testing tools for the early detection of heart disease.
To date, HeartSciences has invested more than $30M in research and development in an effort to fundamentally improve the sensitivity of an electrocardiograph (ECG/EKG) for the early detection of heart disease.
The MyoVista® signal processed ECG (spECG™) Cardiac Testing Device applies proprietary use of Continuous Wavelet Transform (CWT) signal processing technology and represents HeartSciences first product release from years of research and development.